title: Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part I.
abstract: This two-part article, the last in a series of articles on cancer emergencies, summarizes the common medical emergencies that can occur as a result of infectious processes (Part I) and antitumor treatment secondary to chemotherapy, biological response modifiers, or radiotherapy (Part II). The use of high-dose cytotoxic agents, coupled with the common instillation of indwelling central venous access devices, have altered the spectrum of infectious etiologies that are appreciated in clinical practice. In addition, a myriad of cytotoxic agents and radiotherapeutic treatment schemes are used widely in clinical oncologic practice. While most of their related side effects are not considered life-threatening emergencies, they can be fatal if not recognized early and treated promptly. Moreover, some of these infectious and treatment-related sequelae can be prevented.
authors: Division of Oncology, University of Washington School of Medicine, Seattle.
authors: C R
authors: CR
authors: Thomas
authors: L V
authors: LV
authors: Wood
authors: J G
authors: JG
authors: Douglas
authors: K J
authors: KJ
authors: Stelzer
authors: W
authors: W
authors: Koh
authors: R
authors: R
authors: Panicker
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D016026:Bone Marrow Transplantation; D004630:Emergencies; D006801:Humans; D016867:Immunocompromised Host; D007155:Immunologic Factors / Q000009:adverse effects*; D007239:Infections / Q000209:etiology*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011878:Radiotherapy / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D007155:Immunologic Factors